Abbott Hit with $70 Million Verdict in Chicago Infant Formula Injury Case

A Chicago jury has ordered healthcare giant Abbott Laboratories to pay $70 million in damages to the family of an infant who allegedly suffered severe brain damage after consuming its Similac baby formula. The verdict represents a significant legal and financial blow to the company, which has faced intense scrutiny over its infant nutrition products. The case centered on claims that the formula was contaminated with bacteria, leading to a catastrophic infection and permanent neurological injury for the child.

The lawsuit alleged that Abbott's manufacturing processes failed to prevent contamination, directly linking the product to the infant's condition. This verdict follows a series of legal challenges and a major 2022 recall of Abbott's powdered infant formulas, which were connected to bacterial infections and multiple infant deaths, triggering a nationwide shortage. The $70 million award underscores the high stakes for Abbott as it navigates ongoing litigation and attempts to restore public trust in its flagship nutrition brand.

The outcome intensifies pressure on Abbott's legal and reputational defenses, potentially setting a precedent for other pending lawsuits. It also signals to regulators and consumers that courts are willing to hold manufacturers accountable for alleged safety failures in critical products. While Abbott is expected to appeal, the substantial judgment highlights the severe financial and operational risks the company faces from its infant formula portfolio.